Tumor necrosis factor inhibitors

Details for Australian Patent Application No. 2006210778 (hide)

Owner Trustees of The University of Pennsylvania Cephalon, Inc.

Inventors Greene, Mark I.; Xiao, Yingxin; Ottenbrite, Raphael; Cheng, Xin; Murali, Ramachandran

Agent FB Rice

Pub. Number AU-B-2006210778

PCT Pub. Number WO2006/083970

Priority 60/648,973 31.01.05 US

Filing date 31 January 2006

Wipo publication date 10 August 2006

Acceptance publication date 3 November 2011

International Classifications

C07C 69/035 (2006.01) Esters of carboxylic acids

A61K 31/222 (2006.01)

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/083970 Priority application(s): WO2006/083970

27 September 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 Aug 2007

16 June 2011 Alteration of Name

  The name of the applicant has been altered to Trustees of The University of Pennsylvania; Cephalon, Inc.

3 November 2011 Application Accepted

  Published as AU-B-2006210778

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210779-DR5 antibodies and uses thereof

2006210769-BLyS fusion proteins for targeting BLyS receptor and methods for treatment of B-cell proliferative disorders